Download PDF
Am J Perinatol 2017; 34(14): 1389-1395
DOI: 10.1055/s-0037-1603655
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Oropharyngeal Administration of Colostrum Increases Salivary Secretory IgA Levels in Very Low-Birth-Weight Infants

Kristen M. Glass
1   Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania
,
Coleen P. Greecher
2   Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania
,
Kim K. Doheny
1   Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania
3   Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania
› Author Affiliations
Further Information

Publication History

09 July 2016

01 May 2017

Publication Date:
02 June 2017 (online)

    Permissions and Reprints

Abstract

Aim Oropharyngeal administration of colostrum (OAC) has been proposed to provide mother's early milk to very low-birth-weight (VLBW) infants in the first few days of life. The aim of this study was to test the hypothesis that OAC would increase salivary secretory IgA (SsIgA).

Patients and Methods Overall, 30 VLBW infants randomized to receive OAC or sterile water had salivary sampling for SsIgA on the day of life (DOL) 2, 7, and 14. The incidence of late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) was determined prospectively. Within and between-group comparisons were made by paired and independent samples t-tests.

Results Baseline characteristics were similar between groups. SsIgA was higher in OAC versus the control group (p < 0.05) on DOL 7, but not subsequently on DOL 14. There was no difference in LOS or NEC.

Conclusion OAC increased SsIgA at DOL 7. A large, multicenter trial is needed to determine if OAC decreases LOS or NEC in VLBW infants.

Keywords

colostrum - salivary secretory IgA - VLBW infant - infection
 

  • References

  • 1 Stoll BJ, Hansen N, Fanaroff AA. , et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110 (2 Pt 1): 285-291
    CrossrefPubMedGoogle Scholar
  • 2 Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med 2003; 157 (01) 66-71
    CrossrefPubMedGoogle Scholar
  • 3 Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999; 103 (6 Pt 1): 1150-1157
    CrossrefPubMedGoogle Scholar
  • 4 Buescher ES. Anti-inflammatory characteristics of human milk: how, where, why. Adv Exp Med Biol 2001; 501: 207-222
    PubMedGoogle Scholar
  • 5 Garofalo RP, Goldman AS. Cytokines, chemokines, and colony-stimulating factors in human milk: the 1997 update. Biol Neonate 1998; 74 (02) 134-142
    CrossrefPubMedGoogle Scholar
  • 6 Araújo ED, Gonçalves AK, Cornetta MdaC. , et al. Evaluation of the secretory immunoglobulin A levels in the colostrum and milk of mothers of term and pre-term newborns. Braz J Infect Dis 2005; 9 (05) 357-362
    PubMedGoogle Scholar
  • 7 Koenig A, de Albuquerque Diniz EM, Barbosa SF, Vaz FA. Immunologic factors in human milk: the effects of gestational age and pasteurization. J Hum Lact 2005; 21 (04) 439-443
    CrossrefPubMedGoogle Scholar
  • 8 Westerbeek EA, van den Berg A, Lafeber HN, Knol J, Fetter WP, van Elburg RM. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr 2006; 25 (03) 361-368
    CrossrefPubMedGoogle Scholar
  • 9 Rodriguez NA, Meier PP, Groer MW, Zeller JM. Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives. J Perinatol 2009; 29 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 10 Eid P, Meritet JF, Maury C, Lasfar A, Weill D, Tovey MG. Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics. J Interferon Cytokine Res 1999; 19 (02) 157-169
    CrossrefPubMedGoogle Scholar
  • 11 Lecciones JA, Abejar NH, Dimaano EE. , et al. A pilot double-blind, randomized, and placebo-controlled study of orally administered IFN-alpha-n1 (Ins) in pediatric patients with measles. J Interferon Cytokine Res 1998; 18 (09) 647-652
    CrossrefPubMedGoogle Scholar
  • 12 Tovey MG, Meritet JF, Guymarho J, Maury C. Mucosal cytokine therapy: marked antiviral and antitumor activity. J Interferon Cytokine Res 1999; 19 (08) 911-921
    CrossrefPubMedGoogle Scholar
  • 13 Bocci V, von Bremen K, Corradeschi F, Luzzi E, Paulesu L. What is the role of cytokines in human colostrum?. J Biol Regul Homeost Agents 1991; 5 (04) 121-124
    PubMedGoogle Scholar
  • 14 Field CJ. The immunological components of human milk and their effect on immune development in infants. J Nutr 2005; 135 (01) 1-4
    CrossrefPubMedGoogle Scholar
  • 15 Ogawa J, Sasahara A, Yoshida T. , et al. Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants. Early Hum Dev 2004; 77 (1-2): 67-75
    CrossrefPubMedGoogle Scholar
  • 16 Goldblum RM, Schanler RJ, Garza C, Goldman AS. Human milk feeding enhances the urinary excretion of immunologic factors in low birth weight infants. Pediatr Res 1989; 25 (02) 184-188
    CrossrefPubMedGoogle Scholar
  • 17 Schanler RJ, Goldblum RM, Garza C, Goldman AS. Enhanced fecal excretion of selected immune factors in very low birth weight infants fed fortified human milk. Pediatr Res 1986; 20 (08) 711-715
    CrossrefPubMedGoogle Scholar
  • 18 Neu M, Goldstein M, Gao D, Laudenslager ML. Salivary cortisol in preterm infants: Validation of a simple method for collecting saliva for cortisol determination. Early Hum Dev 2007; 83 (01) 47-54
    CrossrefPubMedGoogle Scholar
  • 19 Lee J, Kim HS, Jung YH. , et al. Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics 2015; 135 (02) e357-e366
    CrossrefPubMedGoogle Scholar
  • 20 Rodriguez NA, Meier PP, Groer MW, Zeller JM, Engstrom JL, Fogg L. A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely low-birth-weight infants. Adv Neonatal Care 2010; 10 (04) 206-212
    CrossrefPubMedGoogle Scholar
  • 21 Montgomery D, Baer V, Lambert D, Christensen R. Oropharyngeal administration of colostrum to very low birth weight infants: results of a feasibility trial. Neonatal Intensive Care 2010; 23: 27-29
    PubMedGoogle Scholar
  • 22 Gephart SM, Weller M. Colostrum as oral immune therapy to promote neonatal health. Adv Neonatal Care 2014; 14 (01) 44-51
    CrossrefPubMedGoogle Scholar
  • 23 Spencer J, Macdonald TT. Ontogeny of human mucosal immunity. In: Macdonald TT. , ed. Ontogeny of the Immune System of the Gut. Boca Raton, FL: CRC Press; 1990: 23-50
    Google Scholar
  • 24 Stoll BJ, Lee FK, Hale E. , et al. Immunoglobulin secretion by the normal and the infected newborn infant. J Pediatr 1993; 122 (5 Pt 1): 780-786
    CrossrefPubMedGoogle Scholar
  • 25 Ng PC, Li K, Wong RP. , et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003; 88 (03) F209-F213
    CrossrefPubMedGoogle Scholar
  • 26 Kadaoui KA, Corthésy B. Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer's patches with restriction to mucosal compartment. J Immunol 2007; 179 (11) 7751-7757
    CrossrefPubMedGoogle Scholar
  • 27 Corthésy B. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun Rev 2013; 12 (06) 661-665
    CrossrefPubMedGoogle Scholar
  • 28 Rodriguez NA, Groer MW, Zeller JM. A randomized, controlled trial of the oropharyngeal administration of mother's colostrum to extremely low birth weight infants in the first few days of life. Neonatal Intensive Care 2011; 24 (04) 31-35
    PubMedGoogle Scholar
  • 29 Seigel JK, Smith PB, Ashley PL. , et al. Early administration of oropharyngeal colostrum to extremely low birth weight infants. Breastfeed Med 2013; 8 (06) 491-495
    CrossrefPubMedGoogle Scholar
  • 30 Rodriguez NA, Vento M, Claud EC, Wang CE, Caplan MS. Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial. Trials 2015; 16 (01) 453 . Doi: 10.1186/s13063-015-0969-6
    CrossrefPubMedGoogle Scholar